6th Edition of Global Conference on

Pharmaceutics and Novel Drug Delivery Systems

June 13-14, 2022 | Online Event

Pharmacologic Treatments for COVID-19

Pharmacologic Treatments for COVID-19

The pandemic of coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented challenge in terms of identifying effective prevention and treatment medications. Although some clinical research on traditional antiviral medicines have been undertaken around the world, the outcomes are still inconclusive. In general, the optimal treatment for COVID-19 patients is determined by a number of characteristics, including the disease's stage and symptoms. Administration of drugs among different patient populations may be difficult due to variances in individual genetics in drug metabolism as well as the diversity of immune responses to the coronavirus.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Liwu Li

Liwu Li

Virginia Polytechnic Institute and State University, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Sebastien Fortin

Sebastien Fortin

Laval University, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Vivek Gupta

Vivek Gupta

St. John’s University, United States
PHARMACEUTICS 2022 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Pingsheng Liu

Pingsheng Liu

Chinese Academy of Sciences, China
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Ahmet Dogan Ergin

Ahmet Dogan Ergin

Trakya University/Faculty of Pharmacy, Turkey
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Andre Luiz Pereira

Andre Luiz Pereira

Fundacao Hemominas, Brazil
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Gil Goncalves

Gil Goncalves

University of Aveiro, Portugal

Submit your abstract Today

Watsapp